The 22 most influential people in the fight against COVID-19 CVS' Merlo: Pharmacists can play a key role in easing patients' COVID-19 vaccine fears FDA won't require manufacturing inspections for emergency COVID-19 vaccine use: Bloomberg Sorry, Santa Claus: HHS nixes vaccine-for-promos deal, sidelining North Pole influencers Trump admin updates reporting requirements, grows eligibility for provider relief funds Biopharma roundup: Emergency vaccine nod could scupper ongoing trials; FDA waives site inspections for vaccine OKs Healthcare roundup: UnitedHealth sending out flu season kits to MA members British pharmacy chain sells LumiraDx 12-minute COVID test for consumer use in those without symptoms Insurers taking 'wait and see' approach to COVID-19 in 2021 ACA exchange rates: experts Sanofi, SK flu shots halted in Singapore as South Korea post-vaccination deaths climb to 59 Helix grabs boosted FDA emergency usage for COVID-19 test, can seek out asymptomatic carriers Celltrion nabs emergency use for rapid COVID-19 test from FDA FiercePharmaPolitics—WH chief of staff Meadows says U.S. can't 'control' COVID, but will focus on drugs and vaccines Featured Story | By Eric Sagonowsky For the pharma world, the pandemic has been a crisis with a purpose. Scientists, regulators, biotech companies and drugmakers large and small have taken center stage as they hunt for drugs, vaccines, diagnostic tests and other aids in halting the pandemic. We've chosen 22 of the people who hold our COVID-19 future in their hands. read more |
| |
|---|
|
Top Stories By Paige Minemyer With large numbers of Americans skeptical of a COVID-19 vaccine, CVS views its pharmacists as playing a key role in assuaging fears, CEO Larry Merlo said Friday. read more By Eric Sagonowsky As the leading COVID-19 vaccines move closer to potential emergency use, the research and regulatory processes have been intensely scrutinized. But there’s one area that hasn’t seen as much attention so far—manufacturing facility inspections. read more By Beth Snyder Bulik Official Santa stand-ins had been set to participate in the HHS' $250 million pandemic advertising campaign, in exchange for early access to a COVID-19 vaccine, The Wall Street Journal reported. But the agency's deal with the jolly old elf—and Mrs. Claus and the elves, too—collapsed like a snowman in the sun. read more By Paige Minemyer The Trump administration has updated its reporting requirements for COVID-19 provider relief funds following pushback. read more By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner If the FDA allows emergency use of a vaccine, that could pose challenges for ongoing vaccine trials, experts warned. The agency won't require pre-approval vaccine manufacturing inspections. Diagnostics maker Helix grabbed an expanded OK to offer unsupervised, self-collection of samples and asymptomatic screening. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more By Ben Adams Testing company LumiraDx is selling its pandemic virus rapid test across the U.K. targeting individuals without any COVID-19 symptoms. read more By Robert King Most insurers on the Affordable Care Act’s insurance exchanges aren’t factoring COVID-19 into their 2021 rates or believe the pandemic will have a negligible effect, according to several experts. read more By Angus Liu Deaths after flu vaccination keep rising in South Korea. But as health authorities there work to calm concerned citizens by refuting a connection between the two, Singapore has taken the precautionary measure of suspending two of the vaccines given to people who later died. read more By Ben Adams The FDA has given genomics firm Helix a wider emergency use authorization for its pandemic test. read more By Ben Adams Celltrion has nabbed a speedy preapproval for its quick pandemic virus test as it forecasts high demand. read more By Eric Sagonowsky As U.S. COVID-19 cases surge again, and heading into a winter that officials have warned could be devastating, the White House appears more focused on drugs and vaccines that fight the virus rather than strategies to slow its spread. read more |
